help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chastre, J.
Right arrow Articles by Fagon, J.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chastre, J.
Right arrow Articles by Fagon, J.-Y.

Am. J. Respir. Crit. Care Med., Volume 165, Number 7, April 2002, 867-903

Ventilator-associated Pneumonia

Jean Chastre and Jean-Yves Fagon

Service de Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière; and Service de Réanimation Médicale, Hôpital Européen Georges-Pompidou, Paris, France

Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of patients receiving mechanical ventilation (MV). In contrast to infections of more frequently involved organs (e.g., urinary tract and skin), for which mortality is low, ranging from 1 to 4%, the mortality rate for VAP ranges from 24 to 50% and can reach 76% in some specific settings or when lung infection is caused by high-risk pathogens. The predominant organisms responsible for infection are Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae, but etiologic agents widely differ according to the population of patients in an intensive care unit, duration of hospital stay, and prior antimicrobial therapy. Because appropriate antimicrobial treatment of patients with VAP significantly improves outcome, more rapid identification of infected patients and accurate selection of antimicrobial agents represent important clinical goals. Our personal bias is that using bronchoscopic techniques to obtain protected brush and bronchoalveolar lavage specimens from the affected area in the lung permits physicians to devise a therapeutic strategy that is superior to one based only on clinical evaluation. When fiberoptic bronchoscopy is not available to physicians treating patients clinically suspected of having VAP, we recommend using either a simplified nonbronchoscopic diagnostic procedure or following a strategy in which decisions regarding antibiotic therapy are based on a clinical score constructed from seven variables. Selection of the initial antimicrobial therapy should be based on predominant flora responsible for VAP at each institution, clinical setting, information provided by direct examination of pulmonary secretions, and intrinsic antibacterial activities of antimicrobial agents and their pharmacokinetic characteristics. Further trials will be needed to clarify the optimal duration of treatment and the circumstances in which monotherapy can be safely used.




This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
J. C. Hurley
Profound effect of study design factors on ventilator-associated pneumonia incidence of prevention studies: benchmarking the literature experience
J. Antimicrob. Chemother., May 1, 2008; 61(5): 1154 - 1161.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al.
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
J. Antimicrob. Chemother., April 29, 2008; (2008) dkn162v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
M. Cisz, P.-C. Lee, and A. Rietsch
ExoS Controls the Cell Contact-Mediated Switch to Effector Secretion in Pseudomonas aeruginosa
J. Bacteriol., April 15, 2008; 190(8): 2726 - 2738.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Visscher, E. M. Kruisheer, C. A. M. Schurink, P. J. F. Lucas, and M. J. M. Bonten
Predicting pathogens causing ventilator-associated pneumonia using a Bayesian network model
J. Antimicrob. Chemother., April 4, 2008; (2008) dkn141v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Poelaert, P. Depuydt, A. De Wolf, S. Van de Velde, I. Herck, and S. Blot
Polyurethane cuffed endotracheal tubes to prevent early postoperative pneumonia after cardiac surgery: A pilot study.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 771 - 776.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Sahly, Y. Keisari, E. Crouch, N. Sharon, and I. Ofek
Recognition of Bacterial Surface Polysaccharides by Lectins of the Innate Immune System and Its Contribution to Defense against Infection: the Case of Pulmonary Pathogens
Infect. Immun., April 1, 2008; 76(4): 1322 - 1332.
[Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
C.-C. Lu, H.-C. Lai, S.-C. Hsieh, and J.-K. Chen
Resveratrol ameliorates Serratia marcescens-induced acute pneumonia in rats
J. Leukoc. Biol., April 1, 2008; 83(4): 1028 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Z. Athanassa, I. I. Siempos, and M. E. Falagas
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review
Eur. Respir. J., March 1, 2008; 31(3): 625 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. Pugin, I. Dunn-Siegrist, J. Dufour, P. Tissieres, P.-E. Charles, and R. Comte
Cyclic Stretch of Human Lung Cells Induces an Acidification and Promotes Bacterial Growth
Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 362 - 370.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. D. van Zoelen, S. Florquin, J. C. M. Meijers, R. de Beer, A. F. de Vos, O. J. de Boer, and T. van der Poll
Platelet-Activating Factor Receptor Contributes to Host Defense against Pseudomonas aeruginosa Pneumonia but Is Not Essential for the Accompanying Inflammatory and Procoagulant Response
J. Immunol., March 1, 2008; 180(5): 3357 - 3365.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
I. I. Siempos, K. Z. Vardakas, and M. E. Falagas
Closed tracheal suction systems for prevention of ventilator-associated pneumonia
Br. J. Anaesth., March 1, 2008; 100(3): 299 - 306.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Ramirez, M. A. Garcia, M. Ferrer, J. Aznar, M. Valencia, J. M. Sahuquillo, R. Menendez, M. A. Asenjo, and A. Torres
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
Eur. Respir. J., February 1, 2008; 31(2): 356 - 362.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Sibila, C. Agusti, A. Torres, S. Baquero, S. Gando, J. R. Patron, J. G. Morato, D. H. Goffredo, N. Bassi, and C. M. Luna
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
Eur. Respir. J., December 1, 2007; 30(6): 1167 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 Am J Crit CareHome page
A. M. Berry, P. M. Davidson, J. Masters, and K. Rolls
Systematic Literature Review of Oral Hygiene Practices for Intensive Care Patients Receiving Mechanical Ventilation
Am. J. Crit. Care., November 1, 2007; 16(6): 552 - 562.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Christ-Crain and B. Muller
Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators
Eur. Respir. J., September 1, 2007; 30(3): 556 - 573.
[Abstract] [Full Text] [PDF]

Home page
 Crit Care NurseHome page
B. Augustyn
Ventilator-Associated Pneumonia: Risk Factors and Prevention
Crit. Care Nurse, August 1, 2007; 27(4): 32 - 39.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
F. G. Rios, C. M. Luna, B. Maskin, A. Saenz. Valiente, M. Lloria, S. Gando, C. Sosa, S. Baquero, C. Llerena, C. Petrati, et al.
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Eur. Respir. J., August 1, 2007; 30(2): 307 - 313.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. Masterton, D. Craven, J. Rello, M. Struelens, N. Frimodt-Moller, J. Chastre, A. Ortqvist, G. Cornaglia, H. Lode, H. Giamarellou, et al.
Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development
J. Antimicrob. Chemother., August 1, 2007; 60(2): 206 - 213.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. M. Luna, S. Baquero, S. Gando, J. R. Patron, J. G. Morato, O. Sibila, R. Absi, A. Famiglietti, C. A. Vay, F. Von Stecher, et al.
Experimental Severe Pseudomonas aeruginosa Pneumonia and Antibiotic Therapy in Piglets Receiving Mechanical Ventilation
Chest, August 1, 2007; 132(2): 523 - 531.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
J. Carratala, A. Mykietiuk, N. Fernandez-Sabe, C. Suarez, J. Dorca, R. Verdaguer, F. Manresa, and F. Gudiol
Health Care-Associated Pneumonia Requiring Hospital Admission: Epidemiology, Antibiotic Therapy, and Clinical Outcomes
Arch Intern Med, July 9, 2007; 167(13): 1393 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. Isakow, L. E. Morrow, and M. H. Kollef
Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations
Chest, July 1, 2007; 132(1): 286 - 294.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Horonenko, J. C. Hoyt, R. A. Robbins, C. U. Singarajah, A. Umar, J. Pattengill, and J. M. Hayden
Soluble Triggering Receptor Expressed on Myeloid Cell-1 Is Increased in Patients With Ventilator-Associated Pneumonia: A Preliminary Report
Chest, July 1, 2007; 132(1): 58 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Pierre, M.-O. Husson, R. L. Berre, J.-L. Desseyn, C. Galabert, L. Beghin, C. Beermann, A. Dagenais, Y. Berthiaume, B. Cardinaud, et al.
Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1422 - L1431.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J-M. Boles, J. Bion, A. Connors, M. Herridge, B. Marsh, C. Melot, R. Pearl, H. Silverman, M. Stanchina, A. Vieillard-Baron, et al.
Weaning from mechanical ventilation
Eur. Respir. J., May 1, 2007; 29(5): 1033 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
F. K. Bahrani-Mougeot, B. J. Paster, S. Coleman, S. Barbuto, M. T. Brennan, J. Noll, T. Kennedy, P. C. Fox, and P. B. Lockhart
Molecular Analysis of Oral and Respiratory Bacterial Species Associated with Ventilator-Associated Pneumonia
J. Clin. Microbiol., May 1, 2007; 45(5): 1588 - 1593.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C.-E. Luyt, A. Combes, C. Deback, M.-H. Aubriot-Lorton, A. Nieszkowska, J.-L. Trouillet, F. Capron, H. Agut, C. Gibert, and J. Chastre
Herpes Simplex Virus Lung Infection in Patients Undergoing Prolonged Mechanical Ventilation
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 935 - 942.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
E. Y. Chan, A. Ruest, M. O Meade, and D. J Cook
Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis
BMJ, April 28, 2007; 334(7599): 889 - 889.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Chastre, J.-Y. Fagon, B. Misset, M. Garrouste-Orgeas, J. Carlet, P. E. Marik, M. Baram, D. Heyland, D. Cook, J. Muscedere, et al.
Diagnosis of Ventilator-Associated Pneumonia
N. Engl. J. Med., April 5, 2007; 356(14): 1469 - 1471.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Reinhardt, T. Kohler, P. Wood, P. Rohner, J.-L. Dumas, B. Ricou, and C. van Delden
Development and Persistence of Antimicrobial Resistance in Pseudomonas aeruginosa: a Longitudinal Observation in Mechanically Ventilated Patients
Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1341 - 1350.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. A. Russo, Z. Wang, B. A. Davidson, S. A. Genagon, J. M. Beanan, R. Olson, B. A. Holm, P. R. Knight 3rd, P. R. Chess, and R. H. Notter
Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L632 - L643.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
N. D. Stone, C. M. O'Hara, P. P. Williams, J. E. McGowan Jr., and F. C. Tenover
Comparison of Disk Diffusion, VITEK 2, and Broth Microdilution Antimicrobial Susceptibility Test Results for Unusual Species of Enterobacteriaceae
J. Clin. Microbiol., February 1, 2007; 45(2): 340 - 346.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
O. Burkhardt, V. Kumar, D. Katterwe, J. Majcher-Peszynska, B. Drewelow, H. Derendorf, and T. Welte
Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration
J. Antimicrob. Chemother., February 1, 2007; 59(2): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Am J Crit CareHome page
C. L. Cason, T. Tyner, S. Saunders, and L. Broome
Nurses' Implementation of Guidelines for Ventilator-Associated Pneumonia From the Centers for Disease Control and Prevention
Am. J. Crit. Care., January 1, 2007; 16(1): 28 - 37.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. R. Hoffman, E. Deziel, D. A. D'Argenio, F. Lepine, J. Emerson, S. McNamara, R. L. Gibson, B. W. Ramsey, and S. I. Miller
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa
PNAS, December 26, 2006; 103(52): 19890 - 19895.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. H. Kollef
Diagnosis of Ventilator-Associated Pneumonia
N. Engl. J. Med., December 21, 2006; 355(25): 2691 - 2693.
[Full Text] [PDF]

Home page
 ChestHome page
F. Frutos-Vivar, N. D. Ferguson, A. Esteban, S. K. Epstein, Y. Arabi, C. Apezteguia, M. Gonzalez, N. S. Hill, S. Nava, G. D'Empaire, et al.
Risk Factors for Extubation Failure in Patients Following a Successful Spontaneous Breathing Trial
Chest, December 1, 2006; 130(6): 1664 - 1671.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. E. O. Baleeiro, P. J. Christensen, S. B. Morris, M. P. Mendez, S. E. Wilcoxen, and R. Paine III
GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1246 - L1255.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
S. M. Koenig and J. D. Truwit
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention
Clin. Microbiol. Rev., October 1, 2006; 19(4): 637 - 657.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. N. Jeffres, W. Isakow, J. A. Doherty, P. S. McKinnon, D. J. Ritchie, S. T. Micek, and M. H. Kollef
Predictors of Mortality for Methicillin-Resistant Staphylococcus aureus Health-Care-Associated Pneumonia: Specific Evaluation of Vancomycin Pharmacokinetic Indices.
Chest, October 1, 2006; 130(4): 947 - 955.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. Spies, V. Eggers, G. Szabo, A. Lau, V. von Dossow, H. Schoenfeld, H. Althoff, K. Hegenscheid, B. Bohm, T. Schroeder, et al.
Intervention at the Level of the Neuroendocrine-Immune Axis and Postoperative Pneumonia Rate in Long-term Alcoholics
Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 408 - 414.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
F. R. Stirling and T. J. Evans
Effects of the type III secreted pseudomonal toxin ExoS in the yeast Saccharomyces cerevisiae.
Microbiology, August 1, 2006; 152(Pt 8): 2273 - 2285.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
I. Porzecanski and D. L. Bowton
Diagnosis and treatment of ventilator-associated pneumonia.
Chest, August 1, 2006; 130(2): 597 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Cuzick, F. R. Stirling, S. L. Lindsay, and T. J. Evans
The Type III Pseudomonal Exotoxin U Activates the c-Jun NH2-Terminal Kinase Pathway and Increases Human Epithelial Interleukin-8 Production
Infect. Immun., July 1, 2006; 74(7): 4104 - 4113.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
K. A. Davis
Ventilator-associated pneumonia: a review.
J Intensive Care Med, July 1, 2006; 21(4): 211 - 226.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. E. Craven and R. A. Duncan
Preventing Ventilator-associated Pneumonia: Tiptoeing through a Minefield.
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1297 - 1298.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Koeman, A. J. A. M. van der Ven, E. Hak, H. C. A. Joore, K. Kaasjager, A. G. A. de Smet, G. Ramsay, T. P. J. Dormans, L. P. H. J. Aarts, E. E. de Bel, et al.
Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1348 - 1355.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. H. Kollef
Microbiological Diagnosis of Ventilator-associated Pneumonia: Using the Data to Optimize Clinical Outcomes.
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1182 - 1184.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. G. Hall, Y. Liu, J. M. Hickman-Davis, G. C. Davis, C. Myles, E. J. Andrews, S. Matalon, and J. D. Lang Jr.
Bactericidal Function of Alveolar Macrophages in Mechanically Ventilated Rabbits
Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 719 - 726.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. Afessa, R. D. Hubmayr, E. A. Vetter, M. T. Keegan, K. L. Swanson, L. M. Baddour, F. R. Cockerill III, and S. G. Peters
Bronchoscopy in Ventilator-associated Pneumonia: Agreement of Calibrated Loop and Serial Dilution
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1229 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. Sander, C. von Heymann, V. v. Dossow, C. Spaethe, W. F. Konertz, U. Jain, and C. D. Spies
Increased interleukin-6 after cardiac surgery predicts infection.
Anesth. Analg., June 1, 2006; 102(6): 1623 - 1629.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. H. Kollef, L. E. Morrow, M. S. Niederman, K. V. Leeper, A. Anzueto, L. Benz-Scott, and F. J. Rodino
Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia
Chest, May 1, 2006; 129(5): 1210 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. T. Sadikot, H. Zeng, M. Joo, M. B. Everhart, T. P. Sherrill, B. Li, D.-s. Cheng, F. E. Yull, J. W. Christman, and T. S. Blackwell
Targeted Immunomodulation of the NF-{kappa}B Pathway in Airway Epithelium Impacts Host Defense against Pseudomonas aeruginosa.
J. Immunol., April 15, 2006; 176(8): 4923 - 4930.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. Gregoretti, V. Squadrone, C. Fogliati, C. Olivieri, and P. Navalesi
Transtracheal Open Ventilation in Acute Respiratory Failure Secondary to Severe Chronic Obstructive Pulmonary Disease Exacerbation
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 877 - 881.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
J D Hunter
Ventilator associated pneumonia.
Postgrad. Med. J., March 1, 2006; 82(965): 172 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Kostadima, A. Kaditis, E. Alexopoulos, E. Zakynthinos, and D. Sfyras
From the authors
Eur. Respir. J., February 1, 2006; 27(2): 437 - 438.
[Full Text] [PDF]

Home page
 J Intensive Care MedHome page
S. Fujitani and V. L. Yu
Diagnosis of Ventilator-Associated Pneumonia: Focus on Nonbronchoscopic Techniques (Nonbronchoscopic Bronchoalveolar Lavage, Including Mini-BAL, Blinded Protected Specimen Brush, and Blinded Bronchial Sampling) and Endotracheal Aspirates.
J Intensive Care Med, January 1, 2006; 21(1): 17 - 21.
[Abstract] [PDF]

Home page
 ChestHome page
E. Azoulay, J.-F. Timsit, M. Tafflet, A. de Lassence, M. Darmon, J.-R. Zahar, C. Adrie, M. Garrouste-Orgeas, Y. Cohen, B. Mourvillier, et al.
Candida Colonization of the Respiratory Tract and Subsequent Pseudomonas Ventilator-Associated Pneumonia
Chest, January 1, 2006; 129(1): 110 - 117.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Kollef, D. Pittet, M. Sanchez Garcia, J. Chastre, J.-Y. Fagon, M. Bonten, R. Hyzy, T. R. Fleming, H. Fuchs, L. Bellm, et al.
A Randomized Double-Blind Trial of Iseganan in Prevention of Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 91 - 97.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. H. Kollef, A. Shorr, Y. P. Tabak, V. Gupta, L. Z. Liu, and R. S. Johannes
Epidemiology and Outcomes of Health-care-Associated Pneumonia: Results From a Large US Database of Culture-Positive Pneumonia
Chest, December 1, 2005; 128(6): 3854 - 3862.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J.-C. Lacherade, M. Auburtin, C. Cerf, A. Van de Louw, L. Soufir, Y. Rebufat, S. Rezaiguia, J.-D. Ricard, F. Lellouche, C. Brun-Buisson, et al.
Impact of Humidification Systems on Ventilator-associated Pneumonia: A Randomized Multicenter Trial
Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1276 - 1282.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. S. Burgess and C. R. Frei
Comparison of {beta}-lactam regimens for the treatment of Gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics
J. Antimicrob. Chemother., November 1, 2005; 56(5): 893 - 898.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. F. Shorr and M. H. Kollef
Ventilator-Associated Pneumonia: Insights From Recent Clinical Trials
Chest, November 1, 2005; 128(5_suppl_2): 583S - 591S.
[Abstract] [Full Text] [PDF]